SCHEMBL7955873

SCHEMBL7955873

COc1cccc(CNc2nnc(-c3c[nH]c4ncc(Br)cc34)o2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 8/20 0.55
▸ CDC7 O00311 7/20 0.55
▸ CCNE1 P24864 7/20 0.55
▸ DBF4 Q9UBU7 7/20 0.55
▸ DYRK1A Q13627 4/20 0.45
▸ CLK1 P49759 3/20 0.45
▸ FGFR1 P11362 2/20 0.42
▸ PLK4 O00444 1/20 0.42
▸ AURKA O14965 1/20 0.42
▸ JAK2 O60674 1/20 0.42
▸ ROCK2 O75116 1/20 0.42
▸ PRKD3 O94806 1/20 0.42
▸ MAP4K4 O95819 1/20 0.42
▸ PRKCG P05129 1/20 0.42
▸ INSR P06213 1/20 0.42
▸ CDK1 P06493 1/20 0.42
▸ FES P07332 1/20 0.42
▸ IGF1R P08069 1/20 0.42
▸ ROS1 P08922 1/20 0.42
▸ PHKG2 P15735 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7957150 0.86 CDC7 (0.54) CDK2CDC7CCNE1DBF4DYRK1A
SCHEMBL1557178 0.86 CDC7 (0.74) CDK2CDC7CCNE1DBF4DYRK1A
SCHEMBL16976914 0.85 CDC7 (0.53) CDK2CDC7CCNE1DBF4DYRK1A
SCHEMBL27680371 0.74 KIT (0.67) CDK2DYRK1ACLK1FGFR1PLK4
SCHEMBL878730 0.73 FGFR1 (0.69) CDK2DYRK1AFGFR1PLK4AURKA
SCHEMBL31326317 0.73 KMT2A (0.64) FGFR1FGFR4
SCHEMBL14377770 0.73 PIM1 (0.50) CDK2CDC7CCNE1DBF4PIM1
SCHEMBL2190120 0.72 CDC7 (0.47) CDK2CDC7CCNE1DBF4ROCK2
SCHEMBL2189331 0.72 CDC7 (0.47) CDK2CDC7CCNE1DBF4ROCK2
SCHEMBL15257736 0.72 CDK2 (0.46) CDK2CDC7CCNE1DBF4DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8466170-B2 7-azaindole derivatives MERCK PATENT GMBH (DE) 2013-06-18 — — US disclosed
EP-2303879-B1 7-AZAINDOLE DERIVATIVES MERCK PATENT GMBH (DE) 2012-09-05 — — EP disclosed
US-20110166175-A1 7-AZAINDOLE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-07-07 — — US disclosed
WO-2010020308-A1 7-AZAINDOLE DERIVATIVES MERCK PATENT GMBH (DE) 2010-02-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166175-A1 7-AZAINDOLE DERIVATIVES JAK3, AZI2, MYLK2 CDK2 111/4885CDC7 250/4885CCNE1 187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback